Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Rajnish Wellness
|
Bacil Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.01 % | 0.84 % | -69.0 % |
|
5yr average Equity Multiplier
|
1.42 | 1.34 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
0.08 | 0.53 | 0.0 |
|
5yr Avg Net Profit Margin
|
-205.63 % | 1.14 % | 0.0 |
|
Price to Book
|
1.21 | 0.42 | 1.86 |
|
P/E
|
0.0 | 0.0 | 76.62 |
|
5yr Avg Cash Conversion Cycle
|
124.89 Days | 223.22 Days | 0.0 |
|
Inventory Days
|
3040.44 Days | 39.1 Days | 0.0 |
|
Days Receivable
|
137.33 Days | 226.77 Days | 0.0 |
|
Days Payable
|
1845.08 Days | 44.81 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-2.88 | 5.58 | -943.72 |
|
5yr Avg ROCE
|
-8.17 % | 1.57 % | -75.56 % |
|
5yr Avg Operating Profit Margin
|
-192.46 % | -5.16 % | 0.0 |
|
5 yr average Debt to Equity
|
0.26 | 0.2 | 0.05 |
|
5yr CAGR Net Profit
|
19.73 % | 11.2 % | n/a |
|
5yr Average Return on Assets
|
-6.49 % | 0.61 % | -70.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 9.16 % | 0.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -6.89 % | -42.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Rajnish Wellness
|
Bacil Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|